Your browser doesn't support javascript.
loading
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy.
Baldin, Elisa; Zenesini, Corrado; Antonazzo, Ippazio Cosimo; Bartolomei, Ilaria; Caniatti, Luisa; Costa, Manuela; Curti, Erika; Ferraro, Diana; Foschi, Matteo; Granella, Franco; Guareschi, Angelica; Immovilli, Paolo; Lugaresi, Alessandra; Malagù, Susanna; Mancinelli, Luca; Montepietra, Sara; Mussuto, Vittoria; Neri, Walter; Pasquinelli, Marco; Pellegrino, Lisa; Pesci, Ilaria; Poluzzi, Elisabetta; Pugliatti, Maura; Ravasio, Alessandro; Riise, Trond; Salvi, Fabrizio; Santangelo, Mario; Sireci, Francesca; Sola, Patrizia; Strumia, Silvia; Tsantes, Elena; Vignatelli, Luca; Vitetta, Francesca; Viti, Beatrice; D'Alessandro, Roberto.
Afiliación
  • Baldin E; Epidemiology and Statistics Unit, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Zenesini C; Epidemiology and Statistics Unit, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Antonazzo IC; Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Bartolomei I; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Caniatti L; Neurology Unit, Azienda Ospedaliera-Universitaria, Ferrara, Italy.
  • Costa M; Neurology Unit, Ospedale Ramazzini, Carpi-Modena, Italy.
  • Curti E; Unit of Neurosciences, Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Ferraro D; Neurology Unit, Ospedale Civile, Azienda Ospedaliero-Universitaria, Baggiovara-Modena, Italy.
  • Foschi M; Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Modena, Italy.
  • Granella F; Neurology Unit, Ospedale S. Maria delle Croci, AUSL Romagna, Ravenna, Italy.
  • Guareschi A; Unit of Neurosciences, Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Immovilli P; Neurology Unit, Ospedale di Vaio, Fidenza, Parma, Italy.
  • Lugaresi A; Neurology Unit, Ospedale G. da Saliceto, Piacenza, Italy.
  • Malagù S; UOSI Riabilitazione Sclerosi Multipla, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Mancinelli L; Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
  • Montepietra S; Neurology Unit, Ospedale Bufalini, Cesena, Italy.
  • Mussuto V; Neurology Unit, Ospedale Bufalini, Cesena, Italy.
  • Neri W; Neurology Unit, AUSL, IRCSS Reggio Emilia, Reggio Emilia, Italy.
  • Pasquinelli M; Neurology Unit, Ospedale S.M. Scaletta, Imola, Italy.
  • Pellegrino L; Neurology Unit, AUSL della Romagna, Forlì, Italy.
  • Pesci I; Neurology Unit, Ospedale Infermi, Rimini, Italy.
  • Poluzzi E; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Pugliatti M; Neurology Unit, Ospedale di Vaio, Fidenza, Parma, Italy.
  • Ravasio A; Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Riise T; Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.
  • Salvi F; Neurology Unit, Ospedale Infermi, Rimini, Italy.
  • Santangelo M; Department of Global Public Health and Primary care, University of Bergen, Bergen, Norway.
  • Sireci F; Norwegian Multiple Sclerosis Competence Center, Haukeland University Hospital, Bergen, Norway.
  • Sola P; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Strumia S; Neurology Unit, Ospedale Ramazzini, Carpi-Modena, Italy.
  • Tsantes E; Neurology Unit, AUSL, IRCSS Reggio Emilia, Reggio Emilia, Italy.
  • Vignatelli L; Neurology Unit, Ospedale Civile, Azienda Ospedaliero-Universitaria, Baggiovara-Modena, Italy.
  • Vitetta F; Neurology Unit, AUSL della Romagna, Forlì, Italy.
  • Viti B; Unit of Neurosciences, Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • D'Alessandro R; Epidemiology and Statistics Unit, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Neuroepidemiology ; 55(3): 224-231, 2021.
Article en En | MEDLINE | ID: mdl-33965951
ABSTRACT

INTRODUCTION:

Known risk factors for multiple sclerosis (MS) include smoking, a low vitamin D status, obesity, and EBV, while the inflammatory feature of the disease strongly suggests the presence of additional infectious agents. The association between use of antibiotics and MS risk that could shed light on these factors is still undetermined. We aimed to evaluate the association between antibiotics and MS risk, in the Emilia-Romagna region (RER), Italy.

METHODS:

All adult patients with MS seen at any RER MS center (2015-2017) were eligible. For each of the 877 patients included, clinical information was collected and matched to 5 controls (RER residents) (n = 4,205) based on age, sex, place of residence, and index year. Information on antibiotic prescription was obtained through the linkage with the RER drug prescription database.

RESULTS:

Exposure to any antibiotic 3 years prior to the index year was associated with an increased MS risk (OR = 1.52; 95% CI = 1.29-1.79). Similar results were found for different classes. No dose-response effect was found. DISCUSSION/

CONCLUSIONS:

Our results suggest an association between the use of antibiotics and MS risk in RER population. However, further epidemiological studies should be done with information on early life and lifestyle factors.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antibacterianos / Esclerosis Múltiple Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Europa Idioma: En Revista: Neuroepidemiology Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antibacterianos / Esclerosis Múltiple Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Europa Idioma: En Revista: Neuroepidemiology Año: 2021 Tipo del documento: Article País de afiliación: Italia